Copalspir may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Spiramycin is reported as an ingredient of Copalspir in the following countries:
International Drug Name Search
Betahistine Walmark may be available in the countries listed below.
Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Betahistine Walmark in the following countries:
International Drug Name Search
Starpod may be available in the countries listed below.
Cefpodoxime is reported as an ingredient of Starpod in the following countries:
International Drug Name Search
Kinin Recip may be available in the countries listed below.
Quinine hydrochloride (a derivative of Quinine) is reported as an ingredient of Kinin Recip in the following countries:
International Drug Name Search
Sesugium may be available in the countries listed below.
Timepidium Bromide is reported as an ingredient of Sesugium in the following countries:
International Drug Name Search
Segurite may be available in the countries listed below.
Levonorgestrel is reported as an ingredient of Segurite in the following countries:
International Drug Name Search
Allecet may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Allecet in the following countries:
International Drug Name Search
Dexametonal may be available in the countries listed below.
Dexamethasone 21-acetate (a derivative of Dexamethasone) is reported as an ingredient of Dexametonal in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Methenamine (methenamine systemic) is a member of the drug class urinary anti-infectives and is used to treat Bladder Infection and Prevention of Bladder infection.
US matches:
Rec.INN
J01XX05
0000100-97-0
C6-H12-N4
140
Antibacterial
Urinary tract antiseptic
1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Flemex may be available in the countries listed below.
Carbocisteine is reported as an ingredient of Flemex in the following countries:
International Drug Name Search
Trimetazidin HG. Pharm may be available in the countries listed below.
Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Trimetazidin HG. Pharm in the following countries:
International Drug Name Search
Adco-Quinaretic may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Adco-Quinaretic in the following countries:
Quinapril is reported as an ingredient of Adco-Quinaretic in the following countries:
International Drug Name Search
Paramolan may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paramolan in the following countries:
International Drug Name Search
Quinovid may be available in the countries listed below.
Ofloxacin is reported as an ingredient of Quinovid in the following countries:
International Drug Name Search
Thyradin may be available in the countries listed below.
Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of Thyradin in the following countries:
International Drug Name Search
Uroprot may be available in the countries listed below.
Mesna is reported as an ingredient of Uroprot in the following countries:
International Drug Name Search
Stabisol may be available in the countries listed below.
Hetastarch is reported as an ingredient of Stabisol in the following countries:
International Drug Name Search
Paracetamol-1A Pharma may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paracetamol-1A Pharma in the following countries:
International Drug Name Search
In the US, Invega Sustenna (paliperidone systemic) is a member of the drug class atypical antipsychotics and is used to treat Schizophrenia.
US matches:
Paliperidone is reported as an ingredient of Invega Sustenna in the following countries:
International Drug Name Search
Ceftriaxona Biol may be available in the countries listed below.
Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ceftriaxona Biol in the following countries:
International Drug Name Search
In the US, Relistor (methylnaltrexone systemic) is a member of the drug class peripheral opioid receptor antagonists and is used to treat Constipation - Chronic and Constipation - Drug Induced.
US matches:
UK matches:
Methylnaltrexone Bromide is reported as an ingredient of Relistor in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Brantil may be available in the countries listed below.
Etilefrine hydrochloride (a derivative of Etilefrine) is reported as an ingredient of Brantil in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Megestrol (megestrol systemic) is a member of the following drug classes: hormones/antineoplastics, progestins and is used to treat Abnormal Uterine Bleeding, AIDS Related Wasting, Anorexia, Breast Cancer - Palliative, Cachexia, Endometrial Cancer, Endometrial Hyperplasia, Hot Flashes and Weight Loss.
US matches:
Rec.INN
G03AC05,G03DB02,L02AB01
0003562-63-8
C22-H30-O3
342
Progestin
Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Risperidona Alter may be available in the countries listed below.
Risperidone is reported as an ingredient of Risperidona Alter in the following countries:
International Drug Name Search
Xalkori is a brand name of crizotinib, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Xalkori available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xalkori. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
glye-MEP-ir-ide, roe-zi-GLI-ta-zone MAL-ee-ate
May cause or worsen congestive heart failure, is not recommended in patients with symptomatic heart failure, and is contraindicated in patients with established NYHA Class III or IV heart failure. Monitor patients for signs and symptoms of heart failure after initiation or dose increases and if heart failure occurs, consider dose reducing or discontinuing rosiglitazone maleate and manage according to current standards of care. A meta-analysis of 52 clinical trials (mean duration 6 months; 16,995 total patients), most of which compared rosiglitazone to placebo, showed rosiglitazone to be associated with a statistically significant increased risk of myocardial infarction. Because of the potential increased risk of myocardial infarction, rosiglitazone maleate/glimepiride is available only through a restricted distribution program called the AVANDIA-Rosiglitazone Medicines Access Program. Both prescribers and patients need to enroll in the program. To enroll, call 1-800-AVANDIA or visit www.AVANDIA.com .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antidiabetic
Chemical Class: 2nd Generation Sulfonylurea
Rosiglitazone and glimepiride combination is used to treat a type of diabetes mellitus called type 2 diabetes. It is used together with a proper diet and exercise to help control blood sugar levels.
Rosiglitazone helps your body use insulin better. Glimepiride stimulates the release of insulin from the pancreas which will help your body turn food into energy.
rosiglitazone and glimepiride is only available through a restricted access program. Doctors who are enrolled in the program can write a prescription for rosiglitazone and glimepiride.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For rosiglitazone and glimepiride, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to rosiglitazone and glimepiride or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of rosiglitazone and glimepiride combination in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of rosiglitazone and glimepiride combination in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving rosiglitazone and glimepiride combination.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking rosiglitazone and glimepiride, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using rosiglitazone and glimepiride with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using rosiglitazone and glimepiride with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of rosiglitazone and glimepiride. Make sure you tell your doctor if you have any other medical problems, especially:
Take rosiglitazone and glimepiride only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered.
Carefully follow the special diet your doctor gave you. This is the most important part of controlling your diabetes and will help the medicine work properly. Also, exercise regularly and test for sugar in your blood or urine as directed.
rosiglitazone and glimepiride is only available through a restricted access program. Both you and your doctor must enroll in this program. You might have to sign a consent form in order to receive rosiglitazone and glimepiride and your doctor will closely monitor your progress while you are taking rosiglitazone and glimepiride. Talk to your doctor if you have questions about this.
rosiglitazone and glimepiride should come with a Medication Guide. It is very important that you read and understand this information. Be sure to ask your doctor about anything you do not understand.
rosiglitazone and glimepiride should be taken with the first meal of the day.
The dose of rosiglitazone and glimepiride will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of rosiglitazone and glimepiride. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of rosiglitazone and glimepiride, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check your progress at regular visits to make sure that rosiglitazone and glimepiride is working properly. Blood and urine tests may be needed to check for unwanted effects.
Call your doctor right away if you have chest pain or discomfort; nausea; pain or discomfort in the arms, jaw, back, or neck; shortness of breath; sweating; or vomiting. These may be symptoms of a heart attack.
If you are rapidly gaining weight or having shortness of breath, chest pain or discomfort, extreme tiredness or weakness, irregular breathing, irregular heartbeat, or excessive swelling of the hands, wrist, ankles, or feet, check with your doctor right away. These may be symptoms of a heart problem or edema (fluid retention).
If you have abdominal or stomach pain; dark urine; a loss of appetite; nausea or vomiting; unusual tiredness or weakness; or yellow eyes or skin, check with your doctor right away. These may be symptoms of a serious liver problem.
Check with your doctor right away if blurred vision, difficulty in reading, or any other change in vision occurs while you are taking rosiglitazone and glimepiride. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor).
rosiglitazone and glimepiride may increase the risk for bone fractures in women. Ask your doctor about ways to keep your bones strong to help prevent fractures.
Certain women may be at an increased risk for pregnancy while taking rosiglitazone and glimepiride. If you had problems ovulating and had irregular periods in the past, rosiglitazone and glimepiride may cause you to ovulate. This could increase your chance of becoming pregnant. If you are a woman of childbearing potential, you should discuss birth control options with your doctor.
rosiglitazone and glimepiride may make your skin more sensitive to sunlight. Use a sunscreen when you are outdoors. Avoid sunlamps and tanning beds.
Make sure any doctor or dentist who treats you knows that you are using rosiglitazone and glimepiride. rosiglitazone and glimepiride may affect the results of certain medical tests.
It is very important to carefully follow any instructions from your doctor about:
rosiglitazone and glimepiride can cause hypoglycemia (low blood sugar). Low blood sugar can also occur if you delay or miss a meal or snack, exercise more than usual, drink alcohol, or cannot eat because of nausea or vomiting. The symptoms of low blood sugar must be treated before they lead to unconsciousness (passing out). Different people feel different symptoms of low blood sugar. It is important that you learn which symptoms of low blood sugar you usually have so that you can treat it quickly.
Hyperglycemia (high blood sugar) may occur if you do not take enough or skip a dose of your medicine, overeat or do not follow your meal plan, have a fever or infection, or do not exercise as much as usual.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: rosiglitazone and glimepiride side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
In the US, Lisdexamfetamine (lisdexamfetamine systemic) is a member of the drug class CNS stimulants and is used to treat ADHD, Asperger Syndrome, Chronic Fatigue Syndrome, Narcolepsy and Oppositional Defiant Disorder.
US matches:
Rec.INN
0608137-32-2
C15-H25-N3-O
263
Central stimulant
(2S)-2,6-diamino-N-[(1S)-1-phenylpropan-2-yl]hexanamide (WHO)
(S)-2,6-Diaminhexansäure ((S)-1-methyl-2-phenylethyl)amid (IUPAC)
International Drug Name Search
Glossary
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Minipil may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ethinylestradiol is reported as an ingredient of Minipil in the following countries:
Levonorgestrel is reported as an ingredient of Minipil in the following countries:
Megestrol 17α-acetate (a derivative of Megestrol) is reported as an ingredient of Minipil in the following countries:
International Drug Name Search
Hexaler may be available in the countries listed below.
Desloratadine is reported as an ingredient of Hexaler in the following countries:
International Drug Name Search
There are currently no drugs listed for "Gallstone Ileus".
Definition of Gallstone Ileus: Obstruction of the small intestine produced by passage of a gallstone from the biliary tract (usually the gallbladder as a result of cholecystitis) into the intestinal tract (usually by means of a fistulous connection between the gallbladder and the small intestine); occurrence and site of obstruction depend upon size of the stone, but the usual location is at or near the ileocaecal junction.
Medical Encyclopedia:
Ketotifeno MK may be available in the countries listed below.
Ketotifen is reported as an ingredient of Ketotifeno MK in the following countries:
Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Ketotifeno MK in the following countries:
International Drug Name Search
Berlex may be available in the countries listed below.
Alendronic Acid is reported as an ingredient of Berlex in the following countries:
International Drug Name Search
Simvastatin AWD may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simvastatin AWD in the following countries:
International Drug Name Search
Dermacrin A may be available in the countries listed below.
Enoxolone is reported as an ingredient of Dermacrin A in the following countries:
International Drug Name Search
Glycocolle may be available in the countries listed below.
Glycine is reported as an ingredient of Glycocolle in the following countries:
International Drug Name Search
Sulfosept may be available in the countries listed below.
Zinc Sulfate is reported as an ingredient of Sulfosept in the following countries:
International Drug Name Search
Monotard HM may be available in the countries listed below.
Insulin Zinc Suspension (compound) human (a derivative of Insulin Zinc Suspension (compound)) is reported as an ingredient of Monotard HM in the following countries:
International Drug Name Search
Nüfro may be available in the countries listed below.
Nifuroxazide is reported as an ingredient of Nüfro in the following countries:
International Drug Name Search
Tanap may be available in the countries listed below.
Trandolapril is reported as an ingredient of Tanap in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Octreotide (octreotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Acromegaly, Carcinoid Tumor, Diabetes - Type 1, Diarrhea, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Small Bowel or Pancreatic Fistula and Vasoactive Intestinal Peptide Tumor.
US matches:
UK matches:
Rec.INN
H01CB02
0083150-76-9
C49-H66-N10-O10-S2
1019
Hemostatic agent, gastrointestinal tract
Growth hormone release inhibiting hormone analogue (analogue of somatostatin)
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamido cyclic (2-7) disulfide
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
Penbutololo may be available in the countries listed below.
Penbutololo (DCIT) is known as Penbutolol in the US.
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
Velcox may be available in the countries listed below.
Meloxicam is reported as an ingredient of Velcox in the following countries:
International Drug Name Search
AFI-D2 forte may be available in the countries listed below.
Ergocalciferol is reported as an ingredient of AFI-D2 forte in the following countries:
International Drug Name Search
Devodil may be available in the countries listed below.
Sulpiride is reported as an ingredient of Devodil in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Talwin (pentazocine systemic) is a member of the drug class narcotic analgesics and is used to treat Anesthesia, Labor Pain, Pain and Sedation.
US matches:
Pentazocine hydrochloride (a derivative of Pentazocine) is reported as an ingredient of Talwin in the following countries:
Pentazocine lactate (a derivative of Pentazocine) is reported as an ingredient of Talwin in the following countries:
International Drug Name Search
Cibren may be available in the countries listed below.
Citicoline is reported as an ingredient of Cibren in the following countries:
International Drug Name Search
Docusate Sodium is reported as an ingredient of Phillips`Liqui-Gels in the following countries:
International Drug Name Search
Gentamicin Wagner may be available in the countries listed below.
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamicin Wagner in the following countries:
International Drug Name Search
Avitrol Bird may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Piperonyl Butoxide is reported as an ingredient of Avitrol Bird in the following countries:
Pyrethrin I is reported as an ingredient of Avitrol Bird in the following countries:
International Drug Name Search
Tobradosa may be available in the countries listed below.
Tobramycin is reported as an ingredient of Tobradosa in the following countries:
International Drug Name Search
Rapivir may be available in the countries listed below.
Valaciclovir hydrochloride (a derivative of Valaciclovir) is reported as an ingredient of Rapivir in the following countries:
International Drug Name Search
Tizoxim may be available in the countries listed below.
Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Tizoxim in the following countries:
International Drug Name Search
Aspen Cefuroxime may be available in the countries listed below.
Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Aspen Cefuroxime in the following countries:
International Drug Name Search
Maxiclear Sinus Relief may be available in the countries listed below.
Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Maxiclear Sinus Relief in the following countries:
International Drug Name Search
Ephedronguent may be available in the countries listed below.
Ephedrine hydrochloride (a derivative of Ephedrine) is reported as an ingredient of Ephedronguent in the following countries:
International Drug Name Search
Ubercet may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Ubercet in the following countries:
International Drug Name Search
Oxypan may be available in the countries listed below.
Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Oxypan in the following countries:
International Drug Name Search
Famultran may be available in the countries listed below.
Famotidine is reported as an ingredient of Famultran in the following countries:
International Drug Name Search
Remov may be available in the countries listed below.
Nimesulide is reported as an ingredient of Remov in the following countries:
International Drug Name Search
Canitex may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Permethrin is reported as an ingredient of Canitex in the following countries:
Pyrethrin I is reported as an ingredient of Canitex in the following countries:
International Drug Name Search
Repaglinide/Metformin may rarely cause a serious and sometimes fatal condition called lactic acidosis. Most of these cases have occurred in diabetic patients who also have certain kidney problems. The risk of lactic acidosis may be greater if you have liver problems, kidney problems, or heart failure. The risk may also be greater in patients who are elderly or drink alcohol. Lab tests, including kidney function, may be performed while you take Repaglinide/Metformin.
Do not begin to take Repaglinide/Metformin if you are older than 80 years old unless lab tests show that you do not have decreased kidney function. Do not take it if you have a severe infection, have low blood oxygen levels, or are dehydrated. Tell your doctor you take Repaglinide/Metformin before you have any surgery or lab procedures.
Contact your doctor right away if you notice symptoms such as muscle pain or tenderness; unusual drowsiness, dizziness, or lightheadedness; slow or irregular heartbeat; fast or difficult breathing; unusual stomach discomfort; or unusual weakness or tiredness. Contact your doctor right away if you start to feel unusually cold, or if you have a general feeling of being unwell.
Treating type 2 diabetes. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicines.
Repaglinide/Metformin is a meglitinide and biguanide combination. It works by decreasing the amount of sugar absorbed from food by the intestines and reduces the amount of sugar made in the liver. It also increases the amount of insulin in the blood and helps your body to use insulin and sugar more efficiently. This helps to control blood sugar levels.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Repaglinide/Metformin. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Repaglinide/Metformin. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Repaglinide/Metformin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Repaglinide/Metformin as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Repaglinide/Metformin.
When used for long periods of time, Repaglinide/Metformin may not work as well. If your blood sugar has been under control and then becomes hard to manage, contact your doctor. Do not change the dose of your medicine without checking with your doctor.
All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; gas; headache; indigestion; nausea; stomach upset; temporary metallic taste; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain or discomfort; dark urine; dizziness or lightheadedness; fast or difficult breathing; feeling of being unusually cold; fever, chills, or persistent sore throat; general feeling of being unwell; muscle pain or weakness; slow or irregular heartbeat; unusual drowsiness; unusual or persistent stomach pain or discomfort; unusual tiredness or weakness; yellowing of the skin or eyes.
This is not a complete list of all side effects that may occur. If you have questions or need medical advice about side effects, contact your doctor or health care provider. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dizziness or lightheadedness; fast or difficult breathing; feeling of being unusually cold; general feeling of being unwell; muscle pain or tenderness; slow or irregular heartbeat; unusual drowsiness; unusual stomach discomfort; unusual weakness or tiredness.
Store Repaglinide/Metformin at 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Repaglinide/Metformin out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Repaglinide/Metformin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
